ANTI-HER2-ANTIKÖRPERFORMULIERUNG

Patent europeic · EP2934582 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2934582
Numer da la dumonda
EP13808043
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
18-12-2013
Publitgà
28-10-2015
Concedì
27-11-2019
Stritgà
25-07-2023
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 39/395 (2006.01)
C07K 16/32 (2006.01)
Prioritad
US 201261745293 P 21.12.2012
Dumonda PCT
PCT/EP2013/077166 18.12.2013
Publicaziun PCT
WO2014/096051 26.06.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-07-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 25.07.2023

  2. 14-02-2020

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 14.02.2020

  3. 12-02-2020

    Owner

    Owner
    Glenmark Pharmaceuticals S.A., Chemin de la Combeta, 5, 2300 La Chaux-de-Fonds → Ichnos Sciences SA, Chemin de la Combeta 5, 2300 La Chaux-de-Fonds

    Published in Swissreg on 12.02.2020

  4. 27-11-2019

    Concedì

    Published in Swissreg on 27.11.2019

Partidas

Possessur

IGI Therapeutics SA

Ichnos Sciences SA

Chemin de la Combeta 5, 2300 La Chaux-de-Fonds

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

ALBANESE, Jonathan André

CH-2300 La Chaux-de-Fonds

O'MAHONY, Kevin Niall

CH-2300 La Chaux-de-Fonds

GIOVANNINI, Roberto Pier-Lorenzo

CH-2300 La Chaux-de-Fonds

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.